42 research outputs found
Epitope Mapping of HIV-Specific CD8+ T cells in a Cohort Dominated by Clade A1 Infection
CD8+ T cell responses are often detected at large magnitudes in HIV-infected subjects, and eliciting these responses is the central aim of many HIV-1 vaccine strategies. Population differences in CD8+ T cell epitope specificity will need to be understood if vaccines are to be effective in multiple geographic regions.In a large Kenyan cohort, we compared responsive CD8+ T cell HIV-1 Env overlapping peptides (OLPs) to Best Defined Epitopes (BDEs), many of which have been defined in clade B infection. While the majority of BDEs (69%) were recognized in this population, nearly half of responsive OLPs (47%) did not contain described epitopes. Recognition frequencies of BDEs were inversely correlated to epitopic sequence differences between clade A1 and BDE (P = 0.019), and positively selected residues were more frequent in "new" OLPs (without BDEs). We assessed the impact of HLA and TAP binding on epitope recognition frequencies, focusing on predicted and actual epitopes in the HLA B7 supertype.Although many previously described CD8 epitopes were recognized, several novel CD8 epitopes were defined in this population, implying that epitope mapping efforts have not been completely exhausted. Expansion of these studies will be critical to understand population differences in CD8 epitope recognition
Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight
status: publishe
Probing the Interstellar Medium in Early type galaxies with ISO observations
Four IRAS-detected early type galaxies were observed with ISO. With the
exception of the 15 micron image of NGC1052, the mid-IR emission from NGC1052,
NGC1155, NGC5866 and NGC6958 at 4.5, 7 and 15 microns show extended emission.
Mid-IR emission from NGC1052, NGC1155, and NGC6958 follows a de Vaucouleurs
profile. The ratio of 15/7 micron flux decreases with radius in these galaxies,
approaching the values empirically observed for purely stellar systems. In
NGC5866, the 7 and 15 micron emission is concentrated in the edge-on dust lane.
All the galaxies are detected in the [CII] line, and the S0s NGC1155 and
NGC5866 are detected in the [OI] line as well. The ISO-LWS observations of the
[CII] line are more sensitive measures of cool, neutral ISM than HI and CO by
about a factor of 10-100. Three of four early type galaxies, namely NGC1052,
NGC6958 and NGC5866, have low ratio FIR/Blue and show a lower [CII]/FIR, which
is due to a softer radiation field from old stellar populations. The low
[CII]/CO ratio in NGC5866 ([CII]/CO(1-0) < 570) confirms this scenario. We
estimate the UV radiation expected from the old stellar populations in these
galaxies and compare it to that needed to heat the gas to account for the
cooling observed [CII] and [OI] lines. In three out of four galaxies, NGC1052,
NGC5866 and NGC6958, the predicted UV radiation falls short by a factor of 2-3.
In view of the observed intrinsic scatter in the "UV-upturn" in elliptical
galaxies and its great sensitivity to age and metallicity effects, this is not
significant. However, the much larger difference (about a factor of 20) between
the UV radiation from old stars and that needed to produce the FIR lines for
NGC 1155 is strong evidence for the presence of young stars, in NGC1155.Comment: To appear in the Astrophysical Journal. Figure 1 appears as a
separate jpg figur
Obesity, body composition, and prostate cancer
<p>Abstract</p> <p>Background</p> <p>Established risk factors for prostate cancer have not translated to effective prevention or adjuvant care strategies. Several epidemiologic studies suggest greater body adiposity may be a modifiable risk factor for high-grade (Gleason 7, Gleason 8-10) prostate cancer and prostate cancer mortality. However, BMI only approximates body adiposity, and may be confounded by centralized fat deposition or lean body mass in older men. Our objective was to use bioelectric impedance analysis (BIA) to measure body composition and determine the association between prostate cancer and total body fat mass (FM) fat-free mass (FFM), and percent body fat (%BF), and which body composition measure mediated the association between BMI or waist circumference (WC) with prostate cancer.</p> <p>Methods</p> <p>The study used a multi-centered recruitment protocol targeting men scheduled for prostate biopsy. Men without prostate cancer at biopsy served as controls (n = 1057). Prostate cancer cases were classified as having Gleason 6 (n = 402), Gleason 7 (n = 272), or Gleason 8-10 (n = 135) cancer. BIA and body size measures were ascertained by trained staff prior to diagnosis, and clinical and comorbidity status were determined by chart review. Analyses utilized multivariable linear and logistic regression.</p> <p>Results</p> <p>Body size and composition measures were not significantly associated with low-grade (Gleason 6) prostate cancer. In contrast, BMI, WC, FM, and FFM were associated with an increased risk of Gleason 7 and Gleason 8-10 prostate cancer. Furthermore, BMI and WC were no longer associated with Gleason 8-10 (OR<sub>BMI </sub>= 1.039 (1.000, 1.081), OR<sub>WC </sub>= 1.016 (0.999, 1.033), continuous scales) with control for total body FFM (OR<sub>BMI </sub>= 0.998 (0.946, 1.052), OR<sub>WC </sub>= 0.995 (0.974, 1.017)). Furthermore, increasing FFM remained significantly associated with Gleason 7 (OR<sub>FFM </sub>= 1.030 (1.008, 1.052)) and Gleason 8-10 (OR<sub>FFM </sub>= 1.044 (1.014, 1.074)) after controlling for FM.</p> <p>Conclusions</p> <p>Our results suggest that associations between BMI and WC with high-grade prostate cancer are mediated through the measurement of total body FFM. It is unlikely that FFM causes prostate cancer, but instead provides a marker of testosterone or IGF1 activities involved with retaining lean mass as men age.</p